BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28401338)

  • 21. Prognostic value of human epididymis protein 4 in endometrial cancer and its utility for surgical staging.
    Minar L; Klabenesova I; Jandakova E; Zlamal F; Bienertova-Vasku J
    J Obstet Gynaecol Res; 2015 Oct; 41(10):1644-52. PubMed ID: 26223178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer.
    Chattopadhyay S; Galaal KA; Patel A; Fisher A; Nayar A; Cross P; Naik R
    BJOG; 2012 Sep; 119(10):1162-70. PubMed ID: 22804815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of tumor marker HE4 to predict depth of myometrial invasion in endometrioid adenocarcinoma of the uterus.
    Moore RG; Miller CM; Brown AK; Robison K; Steinhoff M; Lambert-Messerlian G
    Int J Gynecol Cancer; 2011 Oct; 21(7):1185-90. PubMed ID: 21720250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
    Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
    Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.
    Brennan DJ; Hackethal A; Mann KP; Mutz-Dehbalaie I; Fiegl H; Marth C; Obermair A
    BMC Cancer; 2015 Feb; 15():33. PubMed ID: 25655024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of serum HE4 level in the management of endometrial cancer: A pilot study.
    Rajadevan N; McNally O; Neesham D; Richards A; Naaman Y
    Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):284-289. PubMed ID: 33528032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HE4 tumor marker as a predictive factor for lymphatic metastasis in endometrial cancer.
    Espiau Romera A; Cuesta Guardiola T; Benito Vielba M; De Bonrostro Torralba C; Coronado Martín PJ; Baquedano Mainar L
    Int J Gynaecol Obstet; 2020 Jun; 149(3):265-268. PubMed ID: 32147821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management.
    Presl J; Novotny Z; Topolcan O; Vlasak P; Kucera R; Fuchsova R; Vrzalova J; Betincova L; Svobodova S
    Anticancer Res; 2014 Jan; 34(1):327-31. PubMed ID: 24403483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HE4 expression in plasma correlates with surgical outcome and overall survival in patients with first ovarian cancer relapse.
    Braicu EI; Chekerov R; Richter R; Pop C; Nassir M; Loefgren H; Stamatian F; Muallem MZ; Hall C; Fotopoulou C; Sehouli J; Pietzner K
    Ann Surg Oncol; 2014 Mar; 21(3):955-62. PubMed ID: 24217786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
    Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
    Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma.
    Zhang GY; Wu LY; Li B; Huang MN; Zhang R; Li XG
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):309-16. PubMed ID: 23540792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomy.
    Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kinalski M; Terlikowski SJ
    Adv Med Sci; 2016 Mar; 61(1):23-7. PubMed ID: 26344910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients.
    Bignotti E; Ragnoli M; Zanotti L; Calza S; Falchetti M; Lonardi S; Bergamelli S; Bandiera E; Tassi RA; Romani C; Todeschini P; Odicino FE; Facchetti F; Pecorelli S; Ravaggi A
    Br J Cancer; 2011 Apr; 104(9):1418-25. PubMed ID: 21468050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.
    Deng L; Gao Y; Li X; Cai M; Wang H; Zhuang H; Tan M; Liu S; Hao Y; Lin B
    J Exp Clin Cancer Res; 2015 Sep; 34(1):96. PubMed ID: 26362938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of Pelvic MRI and Tumor Markers HE4 and CA125 to Predict Depth of Myometrial Invasion and Cervical Involvement in Endometrial Cancer.
    Zamani N; Modares Gilani M; Zamani F; Zamani MH
    J Family Reprod Health; 2015 Nov; 9(4):177-83. PubMed ID: 27047564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative markers for the prediction of high-risk features in endometrial cancer.
    Panyavaranant P; Manchana T
    World J Clin Oncol; 2020 Jun; 11(6):378-388. PubMed ID: 32874951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative local staging of endometrial cancer: the challenge of imaging techniques and serum biomarkers.
    Angioli R; Plotti F; Capriglione S; Scaletta G; Dugo N; Aloisi A; Piccolo CL; Del Vescovo R; Terranova C; Zobel BB
    Arch Gynecol Obstet; 2016 Nov; 294(6):1291-1298. PubMed ID: 27535757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer.
    Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM
    Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of HE4 in differentiating benign and malignant endometrial pathology.
    Gąsiorowska E; Magnowska M; Iżycka N; Warchoł W; Nowak-Markwitz E
    Ginekol Pol; 2016; 87(4):260-4. PubMed ID: 27321096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.
    Hahn HS; Lee IH; Kim TJ; Lee KH; Shim JU; Kim JW; Lim KT
    Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):293-7. PubMed ID: 23600915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.